Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,024.09 20.57 (1.97%) as of 4:30 Wed 7/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 107.21(B)
Last Volume: 378,341 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 191,758 236,826 311,409 468,643
Total Sell Value $188,359,854 $231,314,072 $294,701,490 $404,818,815
Total People Sold 7 13 16 18
Total Sell Transactions 16 39 65 127
End Date 2024-04-04 2024-01-02 2023-07-04 2022-07-04

   
Records found: 2433
  Page 61 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shooter Eric M Director   –       •      –    2013-11-26 4 A $0.00 $0 I/I 8,185 8,185     -
   Sing George L Director   –       •      –    2013-11-26 4 S $295.00 $2,950,000 D/D (10,000) 112,772     -
   Sing George L Director   –       •      –    2013-11-26 4 OE $15.01 $150,100 D/D 10,000 122,772     -
   Goldstein Joseph L Director   –       •      –    2013-11-06 4 S $300.74 $300,740 D/D (1,000) 3,000     -
   Vagelos P Roy Chairman of the Board   •       •      –    2013-10-09 4 GD $0.00 $0 I/I 679 158,588     -
   Roberts William VP Reg Dev & Med Safety   •       –      –    2013-10-02 5 GA $0.00 $0 I/I 18,399 31,846     -
   Vagelos P Roy Chairman of the Board   •       •      –    2013-10-02 4 GD $0.00 $0 I/I 73,596 1     -
   Schleifer Leonard S President & CEO   •       •      –    2013-10-02 4 AS $312.44 $2,875,253 D/D (9,162) 42,087     -
   Schleifer Leonard S President & CEO   •       •      –    2013-10-01 4 D $313.58 $6,307,348 D/D (20,114) 51,249     -
   Schleifer Leonard S President & CEO   •       •      –    2013-10-01 4 OE $111.01 $3,249,929 D/D 29,276 52,485     -
   Baker Charles A Director   –       •      –    2013-09-30 4 AS $302.46 $4,710,439 D/D (15,000) 9,000     -
   Baker Charles A Director   –       •      –    2013-09-30 4 OE $19.69 $295,350 D/D 15,000 24,000     -
   Brown Michael S Director   –       •      –    2013-09-26 4 AS $309.00 $1,545,000 D/D (5,000) 14,662     -
   Brown Michael S Director   –       •      –    2013-09-26 4 OE $33.42 $167,100 D/D 5,000 19,662     -
   Brown Michael S Director   –       •      –    2013-09-25 4 AS $292.60 $1,468,222 D/D (5,000) 14,662     -
   Brown Michael S Director   –       •      –    2013-09-25 4 OE $33.42 $167,100 D/D 5,000 19,662     -
   Schleifer Leonard S President & CEO   •       •      –    2013-09-19 4 AS $300.33 $31,159,181 D/D (102,949) 42,087     -
   Vagelos P Roy Chairman of the Board   •       •      –    2013-09-19 4 AS $300.34 $44,022,359 D/D (145,356) 65,759     -
   Roberts William VP Reg Dev & Med Safety   •       –      –    2013-09-19 4 GD $0.00 $0 D/D 4,000 16,644     -
   Schleifer Leonard S President & CEO   •       •      –    2013-09-18 4 D $304.38 $35,137,627 D/D (115,440) 145,036     -
   Schleifer Leonard S President & CEO   •       •      –    2013-09-18 4 OE $9.49 $2,072,512 D/D 218,389 260,476     -
   Vagelos P Roy Chairman of the Board   •       •      –    2013-09-18 4 D $304.38 $50,875,291 D/D (167,144) 211,115     -
   Vagelos P Roy Chairman of the Board   •       •      –    2013-09-18 4 OE $13.00 $4,062,500 D/D 312,500 378,259     -
   Roberts William VP Reg Dev & Med Safety   •       –      –    2013-09-18 4 AS $304.00 $4,560,000 D/D (15,000) 20,644     -
   Roberts William VP Reg Dev & Med Safety   •       –      –    2013-09-18 4 OE $16.80 $252,000 D/D 15,000 35,644     -
  2433 Records found
  Previous  60  61  62  63  64  65  66  67  68  69  Next   
  Page 61 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us